source
- Pharvaris reports injectable-like efficacy from once-daily oral pill for rare genetic diseasePharvaris announced that its experimental oral formulation of deucrictibant achieved efficacy comparable to injectable versions in a once-daily pill. The drug is an extended-release version intend…
- FDA halts US shipments from Shoolin Pharma after unsanitary inspection findingsThe Food and Drug Administration issued a warning letter to Shoolin Pharma after an April inspection uncovered unsanitary conditions at its Gujarat facility. The letter cited residue and stains on…